Archive for the ‘top supplements’ Category

Suzanne Somers: How Doctors Used Stem Cell Technology to Rebuild My Breast

Sunday, February 5th, 2012

At 63 years of age, Suzanne Somers is a true inspiration.  In an article from News Max Health (written by Kathleen Walter and Nick Tate), Suzanne shares her latest breakthrough.

Suzanne Somers agonized over the decision to use a  cutting-edge stem cell technology to reconstruct the breast she lost to cancer.  When she began researching the procedure, it wasn’t being offered in the United  States. Women who wanted to have it performed had to travel to Asia, Germany, or  the Dominican Republic.

In an exclusive video interview with Newsmax Health (shown below), Suzanne  details how she was able to work with doctors at Hollywood  Presbyterian Hospital and federal officials to gain approval to become the first  woman in America to undergo the pioneering technique.

It’s the most incredible advancement in breast cancer treatment that I am aware of,” she says.

The procedure itself is enormously complex, but Suzanne  explains the key elements of the technique.

“Here’s my layman’s interpretation,” she says. “They  took fat from my stomach – boo hoo! – they took that fat and in a highly  technical piece of machinery….whipped the stem cells out.”

By separating out the stem cells, doctors could “clean” them and identify the strongest cells, and discard the weakest ones, she says.

“So it was like the fat was just rich with those  [strongest] stem cells,” Suzanne explains. “And then, again in layman’s terms,  they took something that looked to me like a turkey baster and in the bottom of  this breast they kept injecting, injecting, injecting this fat-and-stem-cell  solution until it blew up to be the same size as the other one.”

Today, she says her new breast is very much like the one  she had before her cancer.

“It’s beautiful, it’s soft, it has full feeling. It’s  all me,” she notes. “And there’s no foreign object, and there’s no scar.”

Somers says she felt it was important for her to undergo  the procedure not just for herself, but to help other women with breast cancer in this  country.

“I am the first woman to legally regrow a breast in the  United States,” she says. “It took me three years to get permission … with  Hollywood Presbyterian Hospital, to qualify me for a clinical trial with the  [Food and Drug Administration].”

She wanted to go through the complex experimental  process here – securing approval from a hospital institutional review board  (IRB) and the FDA – so that other women in this country can benefit from her  experience.

“It was important for me to have it done in the United  States because … we’re almost like a Third World country here, relative to stem  cells,” Suzanne says. “Science is supposed to progress. And the fact that  they’ve put up these road blocks with stem cell protocols is pushing back  science. It feels wrong. Most people have to spend their life savings going  offshore to have this done in a country that’s not theirs with doctors they  don’t know.”

She adds: “I wanted it to be an American achievement by  an American doctor  on an American woman so hopefully my clinical trial will open up the possibility  for women in this country to utilize stem cell protocols. And hopefully this  will be the first option in the future. It’s more humane.”

She acknowledges that the procedure is not simple or  easy, and may not be for everyone.

“Liposuction is not for sissies,” she cautions. “When  they removed fat from my stomach — I’m really happy to have given them that fat — but that hurt like crazy.”

Although she extensively researched the procedure before  having it done, she also acknowledges feeling anxious about it, since she was  the first to undergo the procedure.

“I was a human guinea pig because I was the virgin  operation with Dr. Joel Aronowitz,” she says.

But she says the results were worth all the effort,  pain, and anxiety.

“I cannot tell you what a thrill it is to look down and  see myself whole again,” she says.

“I’ve had a hard time keeping my clothes on it looks so  nice!”

She envisions a day when doctors can remove the cancer  from a woman’s breast and immediately take fat “from whatever part of the body  she wants to get rid of it” and regrow her breast using stem cells. She also  believes the procedure might one day be used to replace other body parts — including limbs and heart valves.

“The future is so clearly in nanotechnology and stem  cells, and I actually feel very proud that I might have opened this door a crack  to stem cell protocols,” she says.

“In the future when we’re able to utilize them, you’ll  be able regrow heart valves and, down the road, limbs. Imagine what this might  mean for enlisted people?”

But for now, she says the message is clear: This  stem-cell procedure can work for women with breast cancer, and she feels she’s in the best position to  raise awareness about it.

“Women listen to me,” she says. “I’ve sold 25 million  books around the world, and they look to me as the alternative layperson face. I  wanted to do this not only for me, but I wanted to do this for them. And, in  fact, I saw in the footage when I came out of the ether, the first thing I said — in my drug haze — is this is a great advance for women.”

To see more on Suzanne’s breast reconstruction procedure, go to her website at: suzannesomers.com..

Coming next week to Newsmax Health: How other women can benefit from stem cell  procedures.

Editor’s Note: Suzanne Somers Interviews the Doctors Quietly Curing  Cancer.

© 2012 Newsmax. All rights reserved.

Stem Cell Trachea Transplant

Saturday, January 14th, 2012
As reported on ABC by LARA SALAHI

Christopher Lyles is the first U.S. patient to undergo a tracheal transplant using his own stem cells.

Christopher Lyles, 30, of Abingdon, Md, exhausted the limited treatment options available in the U.S. for his tracheal cancer. But Lyles read about an experimental tracheal transplant procedure surgeons performed in Europe using adult stem cells.

“Every surgeon told me it was inoperable,” said Lyles. “It was hard to hear that.”

Lyles reached out to Dr. Paolo Macchiarini, director of the Advanced Center for Translational Regenerative Medicine at the Karolinska Institute in Stockholm, who was the head surgeon in previous transplant cases.

After a 12 hour procedure in Sweden, Lyles was breathing through a lab grown windpipe that doctors fashioned from his own stem cells.

Doctors regenerated tissue from Lyles bone marrow stem cells to create a trachea biologically identical to Lyles original organ. Lyle underwent the transplant in November and arrived back home Wednesday.

Within three months, Lyles was able to eat and speak on his own, he said.

“I’m going one step further every day,” said Lyle.

According to Dr. Mark Iannettoni, Head of the Department of Cardiothoracic Surgery at University of Iowa, a trachea is a fragile organ because it is mostly cartilage, which has a poor blood supply.

“Once damaged, it is difficult to get it to heal correctly,” said Iannettoni.

In June 2011, Lyles was diagnosed with a rare form of trachea cancer. Unlike some patients with the same condition, Lyles’ tumor extended below his thyroid gland and did not affect his voice box.

Trachea cancer is resistant to chemotherapy and radiation and attempts to replace the trachea with mechanical devices have not been effective.

Lyles’ first underwent seven rounds of chemotherapy and 33 rounds of radiation treatment between July and September.

Using a patient’s own stem cells not only could help to rebuild the fragile tissue, but also potentially could bypass the risk of having the organ rejected, according to Dr. Eric Lambright, surgical director of lung transplant at Vanderbilt University Medical Center, who was not involved with the procedure.

“These patients [are] otherwise sentenced to rather significant horrible quality of life related to their tumors and heroic measures may indeed be very appropriate,” said Lambright.

After surgery, Lyles contracted pneumonia in both lungs, which slowed his recovery.

The experimental procedure, not covered by medical insurance, cost between $300,000 to $600,000, Lyles said.  The family asked for at least $300,000 donation through the non-profit organization Help Hope Live, which works to fund uninsured transplant-related expenses.

“I hope my situation can help other people and we can lobby for those that don’t have a voice,” Lyles said.

Macchiarini and his surgical team have been performing the transplants since 2008, when they  transplanted a trachea using adult stem cells on a woman who suffered from tuberculosis. The procedure was first implemented on patients with tracheal cancer  in August 2010.

According to Macchiarini, the team collected stem cells from the two patients’ nose and bone marrow, and grew two different types of tissues from the cells that resembled the different surfaces of the trachea. The tissues covered the outer and inner linings of the donor trachea.

The team transplanted a new windpipe with tissue grown from her own stem cells and did not need to administer anti-rejection drugs, according to the case report, published in the December 2008 Lancet.

While the procedure seemed to have worked in a few patients, many experts said the method is still in the earliest stages of development.

“This is a research project and not a proven therapy,” said Dr. Larry Goldstein, director of the stem cell program at University of California San Diego. “There’s an important step from innovative therapy to the research needed to bring the innovative therapy to a large number of people.”

In fact, Goldstein said there’s a lot more information needed to know exactly how the procedure worked.

Lambright said it is still early to tell if the procedure works for a larger number of patients.

“We are a long ways away from knowing whether or not any of this has real durable application,” said Lambright.

But Lyles said that without the procedure his doctors told him he may not have been alive today.

“I think this is a viable solution to this type of cancer,” said Lyles. “I’m happy to have been a part of it.”

Macchiarini said this procedure could pave the way for other challenging transplants including the heart valve, chest wall, lungs and the esophagus.

“We need to be very cautious and don’t make hope for patients with cancer, because this is experimental,” said Macchiarini. “But so far the patients have had incredible results for an untreatable cancer.”